Home LiteratureArticle Details
PMID: 1718779 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.

FEBS letters ·Vol. 291 ·No. 1 ·1991-10-07 ·Pages 50-4

Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H

Abstract

Cyclic Arg-Gly-Asp-Phe-Val peptides with either D-Phe or D-Val residues were 20- to more than 100-fold better inhibitors of cell adhesion to vitronectin and/or laminin fragment P1 when compared to a linear variant or Gly-Arg-Gly-Asp-Ser. No or only little increase in inhibitory capacity was observed for fibronectin adhesion and for the binding of platelet receptor alpha IIb beta 3 to fibrinogen. NMR studies of the two most active cyclic peptides showed for both an all-trans conformation with a beta II' and gamma turn. Subtle conformational differences, however, exist between both peptides and may contribute to selectivity of inhibition.

MeSH Terms
Amino Acid Sequence Animals Cell Adhesion Glycoproteins/metabolism Humans Integrins/metabolism Laminin/metabolism Mice Molecular Sequence Data Oligopeptides/chemistry Peptides, Cyclic/chemistry Protein Conformation Structure-Activity Relationship Vitronectin
Chemicals
Glycoproteins Integrins Laminin Oligopeptides Peptides, Cyclic Vitronectin arginyl-glycyl-aspartic acid
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Aumailley M
Max-Planck-Institut für Biochemie, Martinsried, Germany.
Gurrath M
Müller G
Calvete J
Timpl R
Kessler H
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1991-10-07
Pages
50-4
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com